CoronaVac induces lower neutralising activity against variants of concern than natural infection.
Lancet Infect Dis
; 21(10): 1352-1354, 2021 10.
Article
in English
| MEDLINE | ID: covidwho-1372622
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antibodies, Neutralizing
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
Type of study:
Prognostic study
/
Randomized controlled trials
Topics:
Vaccines
/
Variants
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Lancet Infect Dis
Journal subject:
Communicable Diseases
Year:
2021
Document Type:
Article
Affiliation country:
S1473-3099(21)00568-5
Similar
MEDLINE
...
LILACS
LIS